Manufacturer
BAYER HEALTHCARE LLC,
Contents
Antihemophilic factor VIII (recombinant)
Indication
Treatment and prophylaxis of haemorrhagic episodes in patients with haemophilia A and Prophylaxis in severe haemophilia A
Instruction
Administer via Intravenous If refrigerated, warm dried concentrate and diluent to room temperature before reconstitution.
Drug interaction
Not known
Name
Manufacturer
BAYER AG
Contents
Ciprofloxacin
Indication
Infections of the resp tract, middle ear, paranasal sinuses, eyes, kidneys &/or efferent urinary tract, genital organs, abdominal cavity, skin & soft tissues, bones & joints; sepsis, prophylaxis of infections & for selective intestinal decontamination in immunosuppressed patients. Oral: Prophylaxis of invasive infections due to N meningitidis. Inhalational anthrax in adults & childn.
Instruction
May be taken with or without food: May be taken on an empty stomach for better absorption. Do not take w/ dairy products (eg, milk, yoghurt) or mineral-fortified fruit juice (eg, Ca-fortified orange juice).
Drug interaction
Class IA or III antiarrhythmics, multivalent cation-containing prep & mineral supplements, polymeric phosphate binders, sucralfate or antacids, highly buffered drugs containing Mg, Al, Ca, dairy products or mineral fortified drinks. Increased serum conc w/ probenecid. Increased serum conc of tizanidine, theophylline, caffeine, pentoxifylline. Increased absorption w/ metoclopramide. Slight reduction of Cmax & AUC w/ omeprazole. Inhibit renal tubular transport of methotrexate. Induced convulsions w/ NSAIDs. Increased serum creatinine conc w/ cyclosporin. Augmented anticoagulant effects of vit K antagonist. Intensified action of glibenclamide. Increased AUC & Cmax of duloxetine, ropinirole & sildenafil. Reduced clearance of lidocaine IV.
Malaysia
